ReviewBritish journal of cancer2021

Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis.

Monika Sparber-Sauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.